Immediate Impact

68 hit
Sub-graph 1 of 24

Citing Papers

Lipoprotein(a) and cardiovascular disease
2024 Hit
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Hit
2 intermediate papers

Works of Tetsuya Sumiyoshi being referenced

Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)
2009
Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine
1995

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tetsuya Sumiyoshi 209 112 98 47 34 19 291
Mehmet Baltalı 189 0.9× 65 0.6× 69 0.7× 38 0.8× 20 0.6× 23 281
Koji Okino 153 0.7× 68 0.6× 57 0.6× 22 0.5× 15 0.4× 18 283
Jennifer Scovotti 141 0.7× 49 0.4× 167 1.7× 14 0.3× 40 1.2× 20 322
Jun-ping Kang 249 1.2× 55 0.5× 77 0.8× 27 0.6× 8 0.2× 35 316
Th. Weber 240 1.1× 34 0.3× 67 0.7× 21 0.4× 16 0.5× 27 312
Liyew Desta 243 1.2× 60 0.5× 86 0.9× 20 0.4× 5 0.1× 22 323
J. M. Mossard 251 1.2× 86 0.8× 57 0.6× 23 0.5× 17 0.5× 15 325
Gautham Ravipati 153 0.7× 72 0.6× 72 0.7× 81 1.7× 46 1.4× 19 322
Luc Janin-Manificat 187 0.9× 42 0.4× 51 0.5× 64 1.4× 22 0.6× 14 273
Francesco Lauri 136 0.7× 70 0.6× 85 0.9× 36 0.8× 30 0.9× 17 249

All Works

Loading papers...

Rankless by CCL
2026